Synopsis
0
CEP/COS
0
VMF
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
Click Us!
Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.
Chirogate is a professional Prostaglandin manufacturer.
JDMF 
KDMF
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
Capital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Solubilizers
Topical
Film Formers & Plasticizers
Surfactant & Foaming Agents
Emulsifying Agents
Thickeners and Stabilizers
Co-Processed Excipients
Fillers, Diluents & Binders
Direct Compression
Rheology Modifiers
API Stability Enhancers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
73
PharmaCompass offers a list of Tafluprost API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tafluprost manufacturer or Tafluprost supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tafluprost manufacturer or Tafluprost supplier.
PharmaCompass also assists you with knowing the Tafluprost API Price utilized in the formulation of products. Tafluprost API Price is not always fixed or binding as the Tafluprost Price is obtained through a variety of data sources. The Tafluprost Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tafluprost manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tafluprost, including repackagers and relabelers. The FDA regulates Tafluprost manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tafluprost API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tafluprost manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tafluprost supplier is an individual or a company that provides Tafluprost active pharmaceutical ingredient (API) or Tafluprost finished formulations upon request. The Tafluprost suppliers may include Tafluprost API manufacturers, exporters, distributors and traders.
click here to find a list of Tafluprost suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tafluprost DMF (Drug Master File) is a document detailing the whole manufacturing process of Tafluprost active pharmaceutical ingredient (API) in detail. Different forms of Tafluprost DMFs exist exist since differing nations have different regulations, such as Tafluprost USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tafluprost DMF submitted to regulatory agencies in the US is known as a USDMF. Tafluprost USDMF includes data on Tafluprost's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tafluprost USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tafluprost suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tafluprost Drug Master File in Japan (Tafluprost JDMF) empowers Tafluprost API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tafluprost JDMF during the approval evaluation for pharmaceutical products. At the time of Tafluprost JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tafluprost suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tafluprost Drug Master File in Korea (Tafluprost KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tafluprost. The MFDS reviews the Tafluprost KDMF as part of the drug registration process and uses the information provided in the Tafluprost KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tafluprost KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tafluprost API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tafluprost suppliers with KDMF on PharmaCompass.
A Tafluprost written confirmation (Tafluprost WC) is an official document issued by a regulatory agency to a Tafluprost manufacturer, verifying that the manufacturing facility of a Tafluprost active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tafluprost APIs or Tafluprost finished pharmaceutical products to another nation, regulatory agencies frequently require a Tafluprost WC (written confirmation) as part of the regulatory process.
click here to find a list of Tafluprost suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tafluprost as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tafluprost API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tafluprost as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tafluprost and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tafluprost NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tafluprost suppliers with NDC on PharmaCompass.
Tafluprost Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tafluprost GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tafluprost GMP manufacturer or Tafluprost GMP API supplier for your needs.
A Tafluprost CoA (Certificate of Analysis) is a formal document that attests to Tafluprost's compliance with Tafluprost specifications and serves as a tool for batch-level quality control.
Tafluprost CoA mostly includes findings from lab analyses of a specific batch. For each Tafluprost CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tafluprost may be tested according to a variety of international standards, such as European Pharmacopoeia (Tafluprost EP), Tafluprost JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tafluprost USP).
